BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29544747)

  • 1. Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis.
    Hu RJ; Ma JY; Hu G
    Clin Chim Acta; 2018 Jun; 481():142-146. PubMed ID: 29544747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
    Ma JY; Liu Q
    Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
    Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
    World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis.
    Hu RJ; Liu Q; Ma JY; Zhou J; Liu G
    Clin Chim Acta; 2018 Sep; 484():1-6. PubMed ID: 29775617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
    Hu G; Liu G; Ma JY; Hu RJ
    Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.
    Li W; Tao L; Zhang L; Xiu D
    Onco Targets Ther; 2017; 10():3391-3397. PubMed ID: 28744143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
    Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
    Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
    Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
    Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
    J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
    Zhang Y; Liu Y; Qiu X; Yan B
    Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
    [No Abstract]   [Full Text] [Related]  

  • 12. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
    Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
    Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
    He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
    Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis.
    Song W; Tian C; Wang K; Zhang RJ; Zou SB
    Sci Rep; 2017 Apr; 7():46601. PubMed ID: 28417972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma.
    Onoe S; Maeda A; Takayama Y; Fukami Y; Takahashi T; Uji M; Kaneoka Y
    Med Princ Pract; 2019; 28(6):517-525. PubMed ID: 31104057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals.
    Ma JY; Hu G; Liu Q
    Dis Markers; 2019; 2019():7593560. PubMed ID: 31089397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis.
    Wang Y; Huang D; Xu WY; Wang YW; Che GW
    Oncol Res Treat; 2019; 42(10):523-531. PubMed ID: 31319409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
    Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
    Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
    Stotz M; Szkandera J; Stojakovic T; Seidel J; Samonigg H; Kornprat P; Schaberl-Moser R; Seggewies F; Hoefler G; Gerger A; Pichler M
    Clin Chem Lab Med; 2015 Feb; 53(3):499-506. PubMed ID: 25389993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.